Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Lowered to $29 at Citi

May 9, 2024 4:40 PM
Citi analyst David Lebowitz lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $29.00 (from $31.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles